Company: BLNE
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001641172-25-004793
Chunk: 221

Company: Beeline Holdings, Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1A
Chunk 221
---
 be sold by us to such purchaser at our discretion from time-to-time. The purchase price for the shares that we
may sell under the ELOC Agreement will fluctuate based on the price of our Common Stock and will be at a discount to the market prices
of the Common Stock. Depending on market liquidity at the time, sales of such shares may cause the trading price of our Common Stock to
fall. Additionally, the amount that we may sell under the ELOC will be limited to the daily trading dollar volume on the day of, or day
before, the applicable put of shares of Common Stock, as well as certain other limitations set forth in the ELOC Agreement. These limitations
will limit our ability to raise capital under the ELOC Agreement, and may significantly delay the amount of time it takes us to raise
capital thereunder, which could prove harmful to us and our ability to meet our working capital and operational needs through use of the
ELOC Agreement.

Sales by us under the ELOC Agreement
and other financing we may undertake could result in substantial dilution to the interests of other holders of our Common Stock. Additionally,
the sale of a substantial number of shares of our Common Stock, or the anticipation of such sales, could make it more difficult for us
to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.

41

In addition to the ELOC, beginning
in November 2024 and continuing to-date we have offered and sold shares of Series G and Warrants which are convertible and exercisable
for shares of our Common Stock. We have also entered into an engagement letter with a broker-dealer in March 2025 which will be our exclusive
sales agent under an at-the-market offering. Subject to their due diligence and customary conditions, we expect to enter into a definitive
At-the Market Offering Agreement in April 2025. We cannot assure you we will enter into a definitive agreement or receive any proceeds
from the at-the-market offering. If obtaining sufficient funding from these offerings were to prove unavailable or prohibitively dilutive,
we will need to secure another source of funding in order to satisfy our working capital needs. Even if we sell the maximum amount of
$10 million of shares of Common Stock under the ELOC Agreement, we may still need additional capital to fully implement our business,
operating and development plans. Should the financing we require to sustain our working capital needs be unavailable or prohibitively
expensive when we